Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
[Immunotherapies for multiple sclerosis : Review and update.]
Natalizumab to fingolimod: Questions answered, unanswered, and unasked.
FAS-ligand regulates differential activation-induced cell death of human T-helper 1 and 17 cells in healthy donors and multiple sclerosis patients.
[Pulmonary lymphangioleiomyomatosis of unusual revelation during multiple sclerosis].
Peroxisome proliferator activated receptor-γ agonists protect oligodendrocyte progenitors against tumor necrosis factor-alpha-induced damage: Effects on mitochondrial functions and differentiation.
Nutrients, Microglia Aging, and Brain Aging.
Individual Face-to-Face Cognitive Behavioural Therapy in Multiple Sclerosis: A Qualitative Study.
EphrinB1 and EphrinB2 regulate T cell chemotaxis and migration in experimental autoimmune encephalomyelitis and multiple sclerosis.
MHC-class-II are expressed in a subpopulation of human neural stem cells in vitro in an IFNγ-independent fashion and during development.
Clinico-radiologic profile of spinal cord multiple sclerosis in adults.
Brain stem infarction associated with familial Mediterranean fever and central nervous system vasculitis.
Towards patient collaboration in cognitive assessment: Specificity, sensitivity, and incremental validity of self-report.
The molecular study of IFNβ pleiotropic roles in MS treatment.
CD4(+)NKG2D(+) T Cells Exhibit Enhanced Migratory and Encephalitogenic Properties in Neuroinflammation.
Clinical profile and short-term outcomes of optic neuritis patients in India.
Deficiency of CD8+ effector memory T cells is an early and persistent feature of multiple sclerosis.
A task-oriented circuit training in multiple sclerosis: a feasibility study.
Interaction of mTOR and Erk1/2 signaling to regulate oligodendrocyte differentiation.
An investigation of the relationship between latitude and multiple sclerosis severity in New Zealand.
HLA-DRB1*14 is a protective allele for multiple sclerosis in an admixed Colombian population.
Fingolimod effects on left ventricular function in multiple sclerosis.
Neuroprotective arylpiperazine dopaminergic/serotonergic ligands suppress experimental autoimmune encephalomyelitis in rats.
Aquaporin-4 antibody isoform binding specificities do not explain clinical variations in NMO.
Sialic acid-modified antigens impose tolerance via inhibition of T-cell proliferation and de novo induction of regulatory T cells.
Microglia play a major role in direct viral-induced demyelination.
Pages
« first
‹ previous
…
592
593
594
595
596
597
598
599
600
…
next ›
last »